Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
World Journal of Gastroenterology|April 17, 2010
Role of monocytes and macrophages in experimental and human acute liver failureLucia A Possamai, Charalambos Gustav Antoniades, Quentin M Anstee, et al.
Clinical Science (London, England : 1979)|August 13, 2015
Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trialKate Hallsworth, Christian Thoma, Kieren G Hollingsworth, et al.
Frontline Gastroenterology|August 26, 2017
Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experienceJeremy F L Cobbold, Sarrah Raveendran, Christopher M Peake, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USAShraddha Shinde, Mary E Rinella, Mark L Hartman, et al.
Journal of Patient-Reported Outcomes|July 14, 2023
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitisJames Twiss, Diane Whalley, Lynda Doward, et al.
Frontline Gastroenterology|January 13, 2015
Non-alcoholic fatty liver disease is associated with higher levels of <i>objectively</i> measured sedentary behaviour and lower levels of physical activity than matched healthy controlsKate Hallsworth, Christian Thoma, Sarah Moore, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2018
Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern EuropeLaura Haigh, Susan Bremner, David Houghton, et al.
Histopathology|March 1, 2012
Quantifying hepatic steatosis - more than meets the eyeAdam P Levene, Hiromi Kudo, Matthew J Armstrong, et al.
The Patient|December 18, 2020
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative StudyLynda C Doward, Maria-Magdalena Balp, James Twiss, et al.
Plos One|May 6, 2024
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United KingdomJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
World Journal of Gastroenterology|April 17, 2010
Role of monocytes and macrophages in experimental and human acute liver failureLucia A Possamai, Charalambos Gustav Antoniades, Quentin M Anstee, et al.
Clinical Science (London, England : 1979)|August 13, 2015
Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trialKate Hallsworth, Christian Thoma, Kieren G Hollingsworth, et al.
Frontline Gastroenterology|August 26, 2017
Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experienceJeremy F L Cobbold, Sarrah Raveendran, Christopher M Peake, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USAShraddha Shinde, Mary E Rinella, Mark L Hartman, et al.
Journal of Patient-Reported Outcomes|July 14, 2023
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitisJames Twiss, Diane Whalley, Lynda Doward, et al.
Frontline Gastroenterology|January 13, 2015
Non-alcoholic fatty liver disease is associated with higher levels of <i>objectively</i> measured sedentary behaviour and lower levels of physical activity than matched healthy controlsKate Hallsworth, Christian Thoma, Sarah Moore, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2018
Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern EuropeLaura Haigh, Susan Bremner, David Houghton, et al.
Histopathology|March 1, 2012
Quantifying hepatic steatosis - more than meets the eyeAdam P Levene, Hiromi Kudo, Matthew J Armstrong, et al.
The Patient|December 18, 2020
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative StudyLynda C Doward, Maria-Magdalena Balp, James Twiss, et al.
Plos One|May 6, 2024
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United KingdomJesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, et al.
Pageof 27